The alternative NF-κB pathway from biochemistry to biology: Pitfalls and promises for future drug development
Top Cited Papers
- 1 October 2006
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 72 (9) , 1161-1179
- https://doi.org/10.1016/j.bcp.2006.08.007
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral responseNature, 2005
- TRAF2 Differentially Regulates the Canonical and Noncanonical Pathways of NF-κB Activation in Mature B CellsImmunity, 2004
- Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligaseOncogene, 2003
- Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-κB through Distinct Signaling Pathways in Fibroblast Cell LinesJournal of Biological Chemistry, 2003
- Regulation of NF-κB2/p100 processing by its nuclear shuttlingOncogene, 2003
- Modulation of NF-κB Activity by Exchange of DimersMolecular Cell, 2003
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune ResponsesThe Journal of Experimental Medicine, 1998
- Immunological defects in mice with a targeted disruption in Bcl-3.Genes & Development, 1997
- The splenic marginal zone is absent in alymphoplastic aly mutant miceEuropean Journal of Immunology, 1996